L’Oreal SA (EPA: OR)‘s stock had its “outperform” rating restated by analysts at RBC Capital in a research report issued to clients and investors on Tuesday. They currently have a $146.05 (€111) price target on the stock.

A number of other firms have also recently commented on OR. Analysts at Barclays Capital reiterated an “overweight” rating on shares of L’Oreal SA in a research note to investors on Thursday, December 13th. They now have a $151.95 price target on the stock. Separately, analysts at Sanford C. Bernstein reiterated an “underperform” rating on shares of L’Oreal SA in a research note to investors on Tuesday, December 4th. They now have a $122.08 price target on the stock. Finally, analysts at AlphaValue reiterated a “reduce” rating on shares of L’Oreal SA in a research note to investors on Friday, November 30th. They now have a $136.36 price target on the stock.

L’Oreal SA traded up 0.48% on Tuesday, hitting €104.70. L’Oreal SA has a 52-week low of €79.22 and a 52-week high of €107.50. The stock’s 50-day moving average is currently €97.25. The company has a market cap of €62.826 billion and a price-to-earnings ratio of 24.15.

L’Oreal SA is a France-based cosmetic group. It is structured into three branches: Cosmetics, The Body Shop and Dermatology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.